XML 33 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings per Share
 9 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
NOTE 4: EARNINGS PER SHARE
Components of basic and diluted earnings per share and excluded antidilutive potential common shares are as follows:
 
Three Months Ended June 30,
 
Nine Months Ended June 30,
 
2020
 
2019
 
2020
 
2019
 
 
 
 
 
 
 
 
 
(in thousands, except per share amounts)
Net (loss) income from continuing operations attributable to EZCORP (A)
$
(5,467
)
 
$
3,361

 
$
(45,056
)
 
$
3,590

Loss from discontinued operations, net of tax (B)
(20
)
 
(203
)
 
(67
)
 
(404
)
Net (loss) income attributable to EZCORP (C)
$
(5,487
)
 
$
3,158

 
$
(45,123
)
 
$
3,186

 
 
 
 
 
 
 
 
Weighted-average outstanding shares of common stock (D)
55,068

 
55,445

 
55,395

 
55,306

Dilutive effect of restricted stock*
163

 
42

 
88

 
21

Weighted-average common stock and common stock equivalents (E)
55,231


55,487


55,483


55,327

 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to EZCORP:
 
 
 
 
 
 
 
Continuing operations (A / D)
$
(0.10
)
 
$
0.06

 
$
(0.81
)
 
$
0.06

Discontinued operations (B / D)
—

 
—

 
—

 
—

Basic (loss) earnings per share (C / D)
$
(0.10
)
 
$
0.06

 
$
(0.81
)
 
$
0.06

 
 
 
 
 
 
 
 
Diluted (loss) earnings per share attributable to EZCORP:
 
 
 
 
 
 
 
Continuing operations (A / E)
$
(0.10
)
 
$
0.06

 
$
(0.81
)
 
$
0.06

Discontinued operations (B / E)
—

 
—

 
—

 
—

Diluted (loss) earnings per share (C / E)
$
(0.10
)
 
$
0.06

 
$
(0.81
)
 
$
0.06

 
 
 
 
 
 
 
 
Potential common shares excluded from the calculation of diluted earnings per share above*:
 
 
 
 
 
 
 
Restricted stock**
3,042

 
2,891

 
2,677

 
2,804


*
Includes time-based share-based awards and Convertible Note Warrants. See Note 8 for discussion of the terms and conditions of the potential impact of the 2019 Convertible Notes Warrants, 2024 Convertible Notes and 2025 Convertible Notes.
**
Includes antidilutive share-based awards as well as performance-based and market conditioned share-based awards that are contingently issuable, but for which the condition for issuance has not been met as of the end of the reporting period.